Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210340
Status:
WITHDRAWN
Last Update Posted:
2015-03-30
First Post:
2005-09-13
Brief Title:
A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis
Sponsor:
International Extranodal Lymphoma Study Group IELSG
Organization:
International Extranodal Lymphoma Study Group IELSG
Organization Data
Organization:
International Extranodal Lymphoma Study Group IELSG
Class:
OTHER
Study ID:
IELSG24
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
International Extranodal Lymphoma Study Group IELSG
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None